Compare · CLMB vs WGS
CLMB vs WGS
Side-by-side comparison of Climb Global Solutions Inc. (CLMB) and GeneDx Holdings Corp. (WGS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CLMB and WGS operate in Retail: Computer Software & Peripheral Equipment (Technology), so they compete in similar markets.
- WGS is the larger of the two at $2.61B, about 5.1x CLMB ($508.5M).
- WGS has been more active in the news (8 items in the past 4 weeks vs 5 for CLMB).
- WGS has more recent analyst coverage (8 ratings vs 1 for CLMB).
- Company
- Climb Global Solutions Inc.
- GeneDx Holdings Corp.
- Price
- -
- -
- Market cap
- $508.5M
- $2.61B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Retail: Computer Software & Peripheral Equipment
- Retail: Computer Software & Peripheral Equipment
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2020
- News (4w)
- 5
- 8
- Recent ratings
- 1
- 8
Latest CLMB
- Chief Alliance Officer Bass Charles Edward covered exercise/tax liability with 746 shares, decreasing direct ownership by 0.58% to 126,974 units (SEC Form 4) (tax liability)
- Chief Financial Officer Sullivan Matthew M covered exercise/tax liability with 646 shares, decreasing direct ownership by 0.73% to 87,818 units (SEC Form 4) (tax withholding)
- Chief Executive Officer Foster Dale Richard covered exercise/tax liability with 1,015 shares, decreasing direct ownership by 0.30% to 342,452 units (SEC Form 4) (withholding obligation)
- Chief Operating Officer Popovich Timothy covered exercise/tax liability with 222 shares, decreasing direct ownership by 0.38% to 57,891 units (SEC Form 4) (tax withholding)
- Climb Signs Distribution Agreement with Harmonic Security to Help Secure Mid-Market & Enterprise AI Adoption
- Director Bell Peter W was granted 5,855 shares (SEC Form 4)
- SEC Form 10-Q filed by Climb Global Solutions Inc.
- Climb Global Solutions Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Climb Global Solutions Reports Second Quarter 2026 Results
- Climb Global Solutions Sets Second Quarter 2026 Conference Call for July 30, 2026 at 8:30 a.m. ET
Latest WGS
- GeneDx Announces Transformative Study Supporting Hospital-Wide Adoption of Rapid Genomic Sequencing at Seattle Children’s
- SEC Form SCHEDULE 13G filed by GeneDx Holdings Corp.
- GeneDx Launches New Online Offering for Families to Improve Accessibility of Exome Testing for Children with Global Developmental Delay, Intellectual Disability and Epilepsy
- Amendment: SEC Form SCHEDULE 13G/A filed by GeneDx Holdings Corp.
- GeneDx to Participate in Upcoming Investor Conferences
- SEC Form 10-Q filed by GeneDx Holdings Corp.
- GeneDx Holdings Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- GeneDx Reports Second Quarter 2026 Financial Results
- SEC Form 25-NSE filed by GeneDx Holdings Corp.
- GeneDx to Report Second Quarter 2026 Financial Results on Monday, August 3, 2026